Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

AMBS

Amarantus Bioscience Holdings, Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

AMBS:Amarantus Bioscience Holdings, Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$0.04

EXCHANGE

OTCBB

SECTOR

Health Care

AMBS
Amarantus Bioscience Holdings, Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
AMBS
Amarantus Bioscience Holdings, Inc Stock Information
Latest Close Price$0.04
52-Week Low/High$0.02 - $0.11
Percent Held by Institutions0.06%
Revenue$0
Net Income$-5,329,758
Cash Flow$98,904
EPS0.00%
Market Cap$2,887,906
PE Ratio0
PE Ratio to Industry66%
Debt-Equity Ratio999,999.00%
Debt-Equity to Industry1.38%
Total Return Last 12 Months-53.00%
Total Return Last 3 Years-88.63%
Total Return Last 5 Years-99.70%
Latest Trade DateJan. 18, 2019
AMBS
Amarantus Bioscience Holdings, Inc Dividend Payment History

No Data available for Payment History.

AMBS
Amarantus Bioscience Holdings, Inc Other Details

Amarantus Bioscience Holdings is a biopharmaceutical holding company. Through its subsidiaries, Co. owns or has licenses to various product candidates in the therapeutic and diagnostic sectors of the life sciences industry. Co. is developing a regenerative medicine cell therapy-based autologous skin replacement product called Engineered Skin substitute in mid-stage clinical development for the treatment of life-threatening severe burns. Co. is also developing a mid-stage clinical stage pharmaceutical drug candidate, Eltoprazine, as a symptomatic treatment for Parkinson's disease levodopa-induced dyskinesias, Attention Hyperactivity Disorder, and Alzheimer's disease-related aggression.

Web Sitewww.amarantus.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Amarantus Bioscience Holdings, Inc Dividend Stock News and Updates

Jan. 16, 2019CLOSE PRICE INCREASE: Amarantus Bioscience Holdings, Inc (OTCBB: AMBS) on 01-16-2019 increased close price > 10% from $0.04 to $0.04

Read more...

Jan. 12, 2019CLOSE PRICE INCREASE: Amarantus Bioscience Holdings, Inc (OTCBB: AMBS) on 01-12-2019 increased close price > 10% from $0.02 to $0.04

Read more...

Jan. 05, 2019CLOSE PRICE INCREASE: Amarantus Bioscience Holdings, Inc (OTCBB: AMBS) on 01-05-2019 increased close price > 10% from $0.02 to $0.02

Read more...
More Amarantus Bioscience Holdings, Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Jan. 19, 2019CLOSE PRICE INCREASE: Acura Pharmaceuticals Inc (OTCBB: ACUR) on 01-19-2019 increased close price > 10% from $0.13 to $0.16

Read more...

Jan. 19, 2019CLOSE PRICE INCREASE: Aradigm Corp. (OTCBB: ARDM) on 01-19-2019 increased close price > 10% from $0.55 to $0.61

Read more...

Jan. 19, 2019CLOSE PRICE INCREASE: Burzynski Research Institute Inc (OTCBB: BZYR) on 01-19-2019 increased close price > 10% from $0.03 to $0.04

Read more...
More Pharmaceuticals Dividend News
X

Search Dividend Investor